Discussing Histopathology - Past, Present, Future
Insightful discussion on histopathology's evolution, covering training, research, molecular and digital advancements, specialization, autopsies, and career choices, from two pathologists of different generations.
RCPath and BDIAP Foundation and Undergraduate Pathology Taster Event
Explore pathology careers: training, opportunities, application advice, and research prospects. Gain insights from experts and hear experiences of foundation doctors in this comprehensive overview.
Heterogeneity of Breast Cancer Genomes: Going Beyond Therapy to Risk Assessment and Prevention
Explore breast cancer genome heterogeneity, focusing on risk assessment and prevention strategies beyond therapy. Gain insights from expert Olufunmilayo Olopade at the CGC 2023 Annual Meeting.
Analyzing Historical Mutations in the Cystic Fibrosis Gene - Ambry Genetics
Genetic counselors analyze CFTR gene mutations, discussing reclassified variants and implications for genetic testing in cystic fibrosis and related disorders.
TP53 Alterations in Myelodysplastic Neoplasms and Acute Myeloid Leukemia
Explore TP53 alterations in myelodysplastic neoplasms and acute myeloid leukemia, gaining insights from expert Joseph Khoury at the CGC 2023 Annual Meeting.
Incorporating Genomic Information in the Treatment of MDS
Explore genomic information's role in treating Myelodysplastic Syndrome (MDS). Gain insights into cutting-edge approaches for accurate diagnosis and personalized therapy in cancer genomics.
WHO/IARC Overview and CGC Collaboration
Explore WHO/IARC's collaboration with CGC, focusing on best practices in clinical cancer genomics and accurate diagnosis for targeted therapy.
Cytogenetics in the Era of Genomics - Invited Speaker Presentation
Explore the continued relevance of cytogenetics in modern genomics, highlighting its crucial role in cancer diagnosis and treatment strategies.
NPM1 Mutation in Myeloid Malignancies - Advancing Precision Medicine
Explore NPM1 mutations in myeloid malignancies and their impact on precision medicine through molecular testing. Gain insights from expert Robert Hasserjian on advancing cancer diagnostics and treatment.
Genetic Ancestry, Somatic Alteration and Outcome in Cancer Genomics - Invited Presentation
Explore the relationship between genetic ancestry, somatic alterations, and cancer outcomes in this insightful presentation by Jian Carrot-Zhang at the 2022 CGC Annual Meeting.
Long Molecule Footprints of Complex Cancer Genome Structure - Invited Presentation
Explore complex cancer genome structures through long molecule footprints. Gain insights into advanced genomic analysis techniques for accurate cancer diagnosis and personalized treatment.
Translating Human Readable Variation Descriptions to Unique Computable Variations with the Variation Normalizer
Learn to translate human-readable genetic variation descriptions into unique computable variations using the Variation Normalizer tool for improved cancer genomics analysis and diagnosis.
Two Co-occurring Driver Mutations in Primary Lung Adenocarcinoma - Who's Driving Treatment?
Explore co-occurring driver mutations in lung adenocarcinoma, their impact on RAS signaling, and implications for targeted therapies. Gain insights into clinical cases and treatment strategies.
Epigenetic Reprogramming of Brain Development Pathways During Non-Small Cell Lung Cancer Metastasis
Explore epigenetic reprogramming in brain development pathways during non-small cell lung cancer metastasis. Gain insights into cutting-edge cancer genomics research and its implications for diagnosis and treatment.
SNP Array Analysis of Borderline Melanocytic Tumors
Explore SNP array analysis techniques for borderline melanocytic tumors, enhancing diagnostic accuracy and treatment decisions in cancer genomics.
Integrative Cytogenetic and Molecular Studies Unmasks Chromosomal Mimicry in Hematologic Malignancies
Explore integrative cytogenetic and molecular studies revealing 'Chromosomal Mimicry' in hematologic malignancies, enhancing accurate diagnosis and targeted therapy for cancer patients.
Frequency and Etiology of Cytogenetically Cryptic Oncogenic Fusions in Pediatric AML
Explore cytogenetically cryptic oncogenic fusions in pediatric AML, examining their frequency and etiology to enhance diagnostic accuracy and treatment approaches.
Mapping Variants from Multiplex Assays of Variant Effect to Human Reference Sequences
Learn to map variants from multiplex assays of variant effect (MAVEs) to human reference sequences, enhancing accuracy in clinical cancer genomics and improving patient diagnosis and treatment.
Clinical, Cytogenetic and Genomic Profiling of B-Other Acute Lymphoblastic Leukemia - An Indian Cohort Study
Explore clinical, cytogenetic, and genomic profiling of B-Other Acute Lymphoblastic Leukemia in an Indian cohort study. Gain insights into cancer genomics and its impact on accurate diagnosis and treatment.
Association Between Clonal Hematopoiesis and Inherited Cancer Susceptibility Genes
Explore the link between clonal hematopoiesis and inherited cancer susceptibility genes in this concise presentation from the 2022 CGC Annual Meeting.
Unraveling the Roles of Copy Number Variants in Tumorigenesis
Explore genomic analysis of cancer cells, focusing on Copy Number Variants (CNVs) as biomarkers and their detection through OncoScan CNV assays for understanding tumor development and progression.